Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

(2015)   Oncotarget

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment

(2015) Eddy Pasquier et al.   Oncotarget

Beta blocker use and colorectal cancer risk

(2012) Lina Jansen et al.   CANCER

Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis

(2012) G. Nkontchou et al.   Cancer Prevention Research

Impact of beta blockers on epithelial ovarian cancer survival

(2012) Elena S. Diaz et al.   GYNECOLOGIC ONCOLOGY

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

(2011) Patricia A. Ganz et al.   BREAST CANCER RESEARCH AND TREATMENT

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study

(2011) Sunil M. Shah et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

 -Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study

(2011) S. Lemeshow et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction

(2011) Tao Shan et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

(2011) Thomas I. Barron et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

(2011) Amal Melhem-Bertrandt et al.   JOURNAL OF CLINICAL ONCOLOGY

Antiangiogenic effects of β2-adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy

(2011) Davide Martini et al.   JOURNAL OF NEUROCHEMISTRY

Prevention of pancreatic cancer by the beta-blocker propranolol

(2010) Hussein A. Al-Wadei et al.   ANTI-CANCER DRUGS

Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491

(2010) Luca Filippi et al.   BMC Pediatrics

The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

(2010) E. K. Sloan et al.   CANCER RESEARCH

Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

(2010) M. Monami et al.   DIABETES CARE

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

(2010) E. Mannucci et al.   DIABETES CARE

Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism

(2010) Soon Young Park et al.   INTERNATIONAL JOURNAL OF CANCER

Expression of β2-adrenergic receptor in oral squamous cell carcinoma

(2010) Zheng Jun Shang et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Importance of blood pressure control in left ventricular mass regression

(2010) Alan B. Miller et al.   Journal of the American Society of Hypertension

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

(2010) Sripal Bangalore et al.   LANCET ONCOLOGY

Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened

(2009) Gary D. Friedman et al.   CANCER CAUSES & CONTROL

Catecholamines Regulate Tumor Angiogenesis

(2009) D. Chakroborty et al.   CANCER RESEARCH

Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma

(2009) J.-W. Lee et al.   CLINICAL CANCER RESEARCH

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials

(2009) Craig I Coleman et al.   JOURNAL OF HYPERTENSION

Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes

(2009) Michael Mauer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression

(2008) Eric V. Yang et al.   BRAIN BEHAVIOR AND IMMUNITY

Determinants of New-Onset Diabetes Among 19,257 Hypertensive Patients Randomized in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm and the Relative Influence of Antihypertensive Medication

(2008) A. K. Gupta et al.   DIABETES CARE

Is norepinephrine an etiological factor in some types of cancer?

(2008) Paul J. Fitzgerald   INTERNATIONAL JOURNAL OF CANCER

Propranolol for Severe Hemangiomas of Infancy

(2008) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibition of Pancreatic Cancer Cell Proliferation by Propranolol Occurs Through Apoptosis Induction

(2008) Dong Zhang et al.   PANCREAS